Learn About Abattis
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal and adult marijuana markets in North America.
Abattis Bioceuticals Corp. (OTC: ATTBF)
Latest price $ 0.26 Volume 61495
(10-21-2014 12:39 EST)
Abattis Bioceuticals Corp. (CSE: ATT)
(Click here to view CSE quote)